Emergency department-administered, high-dose buprenorphine may enhance opioid use disorder treatment outcomes
National Institutes of Health (NIH) sent this bulletin at 07/15/2021 11:30 AM EDTHaving trouble viewing this email? View it as a Web page.
You are receiving this message because you are subscribed to News Releases for National Institutes of Health (NIH).
07/15/2021 11:00 AM EDT
Elevated doses of the medication may provide a critical extended period of withdrawal relief.
|
Update Your E-mail Address | Add Subscriptions | Unsubscribe All If you have questions or problems with the subscription service, please contact subscriberhelp.govdelivery.com. For all other inquiries about NIH programs and activities, please contact Ask NIH. Before writing, please view our Frequently Asked Questions page, our Health Information page, or Search our website. This service is provided to you by the National Institutes of Health.
|
